On a roll in Ireland, Alexion plots 200-job supply chain hub

Alexion ($AXLN), like many of its pharma peers, has moved some operations to Ireland to enjoy the country's low tax rate. Now, it's beefing up those operations: Thursday, the rare-disease drugmaker announced plans for its third Irish project, a new supply-chain facility that should produce around 200 jobs come 2016. More

Suggested Articles

Novartis is taking its MBC campaign to Instagram with a newly launched video series as part of the five-year “Make Your Dialogue Count” effort.

FDA researchers uncover more concerns and fears among front-line workers and minority groups about a COVID-19 vaccine.

As COVID-19 vaccines advance, the FDA held an expert hearing Thursday to talk safety, efficacy, distribution plans and vaccine confidence—plus more.